Finanzen von 180 Life Sciences Corp (ATNF)ATNF180 Life Sciences Corp

Evaluating the bottom line, 180 Life Sciences Corp maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -458.57%, provide a clear picture of how effectively ATNF converts its operational activities into shareholder value.

In the context of the broader market, ATNF competes directly with industry leaders such as KTTA and SNGX. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, ATNF's gross margin of N/A stands against KTTA's N/A and SNGX's N/A. Such benchmarking helps identify whether 180 Life Sciences Corp is trading at a premium or discount relative to its financial performance.